News | March 18, 2024
AstraZeneca to acquire Amolyt Pharma
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
It is the first autotaxin inhibitor to be investigated in cancer patients
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today
Gross profit was Rs. 313.3 crore, up by +30.4% YoY with a Gross margin of 53.5%
Subscribe To Our Newsletter & Stay Updated
